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ABSTRACT 
We performed a genome-wide association study (GWAS) and a multi-stage meta-analysis of type 2 
diabetes (T2D) in Punjabi Sikhs from India. Our discovery GWAS in 1,616 individuals (842 cases) was 
followed by in silico replication of the 513 independent SNPs (P<10-3) in Punjabi Sikhs (n=2,819/801 
cases). We further replicated 66 SNPs (P<10-4) through genotyping in a Punjabi Sikh sample 
(n=2,894/1,711 cases). On combined meta-analysis in Sikh populations (n=7,329/3,354 cases), we 
identified a novel locus in association with T2D at 13q12 in a directly genotyped intronic SNP (rs9552911, 
P= 1.82x10-8) in the SGCG gene. Next, we undertook in silico replication (Stage 2b) of the top 513 signals 
(P<10-3) in 29,157 non-Sikh South Asians (10,971 cases) and de novo genotyping of up to 31 top signals 
(P<10-4) in 10,817 South Asians (5,157 cases) (Stage 3b). In combined South Asian meta-analysis, we 
observed six suggestive associations (P<10-5 to <10-7), including SNPs at HMG1L1/CTCFL, PLXNA4, SCAP 
and chr5p11. Further evaluation of 31 top SNPs in 33,707 East Asians (16,746 cases) (Stage 3c) and 47,117 
Europeans (8,130 cases) (Stage 3d), and joint meta-analysis on 128,127 individuals (44,358 cases) from 27 
multi-ethnic studies did not reveal any additional loci, neither there was any evidence of replication for 
the new variant. Our findings provide new evidence on the presence of a population-specific signal in 
relation to T2D, which may provide additional insights to T2D pathogenesis.   
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Introduction 
South Asians (people from the Indian Sub-continent) comprise more than a quarter of the global 
population and contribute the highest number of patients with type 2 diabetes (T2D) 1. According to latest 
estimates, ~61 million people in India alone are currently affected with T2D, and their number is projected 
to increase to ~101 million by 2030 2.  About 60% of the world’s coronary artery disease (CAD), a principal 
cause of mortality in individuals with T2D, is expected to occur in India 3. There is considerable ethnic 
difference in the prevalence and progression of T2D and CAD. In addition to the environmental factors, 
genetic factors influence disease susceptibility 4.  The incidence of T2D and CAD s about 3-5 times higher 
in immigrant South Asians compared to Euro-Caucasians and the age of onset of T2D is roughly a decade 
earlier in South Asians than in Europeans 5-7. Higher prevalence of T2D among South Asians settled in 
developed countries compared to the host population reflects the genetic and ethnic predisposition to 
cardio-metabolic disease under an adverse environment, and joint effects of genes and environment 
predisposing to T2D8. For these reasons, we conducted ethnic-specific genetic studies in a Sikh population 
to dissect genetic pathways that may contribute to T2D etiology in different ethnic groups.  
 
The vast majority of genome-wide association studies (GWAS) on T2D so far have been performed in 
Europeans. Studies on non-European populations, especially those with unique demographic and cultural 
histories are important to identify population-specific linkage disequilibrium (LD) patterns and 
environmental factors  that may modulate disease risk or protection 9.  Interestingly, many but not all of 
the common loci originally identified in Europeans have been replicated in non-European groups 10-18. 
Recent GWAS in non-European populations have yielded intriguing new variants 19,20  21. including six novel 
signals in South Asians represented by SNPs near GRB14, ST6GAL1, VPS26A, HMG20A, AP3S2 and HNF4A 
in our recent meta-analysis of GWAS 22. Given the existence of strong genetic and ethnic diversity among 
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South Asian communities, they do not constitute a single homogeneous community23. Therefore, 
screening South Asians with different genetic and racial background or environmental exposures may 
improve insights about the disease and genetic risk factors 24.  
 
People from India have a complex racial history complicated by the presence of caste system which has 
prohibited inter-breeding to greater extent and has separated people into numerous endogamous groups 
25. Presently, the Sikhs,  a relatively younger inbred population of ~26 million (2% of Indian population), is 
from the North Western province of India that follows a distinct and unique religion born 500 years ago in 
Punjab. They have an interesting background for ‘nontraditional’ disease enrichment in the absence of 
conventional risk factors such as smoking, obesity, and diet rich in meats 26. Sikhs do not smoke or chew 
tobacco because of religious and cultural compulsions and ~50% of them are lifelong vegetarians. Despite 
the absence of these life style related risk factors, T2D and CAD have  reached epidemic scale in Sikhs.  
Our initial genetic studies in a Sikh cohort as part of Asian Indian Diabetic Heart Study or the Sikh Diabetes 
Study (AIDHS/SDS) revealed association of FTO and MTNR1B, ADIPOQ and PPARG polymorphisms with 
T2D and risk factors in the absence of obesity 11,27,28. In this investigation, we conducted a GWAS in a 
relatively homogenous Punjabi Sikh population of 1,850 individuals and performed multi-stage replication 
with up to 27 case-control studies of Punjabi, other South Asian, East Asian and Caucasian ancestries (total 
n=128,127;  44,358 T2D cases and 83,769 controls) (Supplementary Tables 1,2). Study design of the 
discovery, replication, and meta-analyses phases was optimized to detect new population-specific and 
multi-ethnic T2D loci (Figure 1). One important difference in our present study from our previous South 
Asian GWAS 22 is that in previous study, the SNPs that were common between South Asians and 
Europeans were selected for replication using European sample from DIAGRAM.  However, in this 
study, the SNPs selection was prioritized based on the top signals (P<10-3) from our discovery Sikh 
cohort. 
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Methods 
Participants 
Punjabi Sikh GWAS 
Study sample and characteristics  
Our primary Sikh GWAS (discovery) cohort used in this investigation is comprised of 1,616 individuals from 
the Punjabi Sikh population which was part of the Asian Indian Diabetic Heart Study also named the Sikh 
Diabetes Study (AIDHS/SDS). The AIDHS/SDS has unique characteristics that are ideal for genetic studies. 
Sikhs are strictly a non-smoking population and about 50% of participants are teetotalers and life-long 
vegetarians.  All individuals for the GWAS discovery cohort were recruited from one geographical location. 
Diagnosis of T2D was confirmed by scrutinizing medical records for symptoms, use of medication, and 
measuring fasting glucose levels following the guidelines of the American Diabetes Association 29, as 
described previously 11. Lipids, insulin, glucose, anthropometric measurements, education, socio-
economic status, job grade, dietary and physical activity are available on >95% of the AIDHS/SDS 
individuals selected for this study. Dietary questions involving alcohol consumption were scored using a 
scale from 0-5, details are described elsewhere26. T2D is often asymptomatic and remains undiagnosed 
for many years especially in people from the developing world due to poor healthcare provisions. 
Therefore, it is reasonable to assume that the actual age of onset of T2D in Sikhs may range between 39-
42 years compared to the observed age at diagnosis (46 years). This age is in sharp contrast to the mean 
age at onset of 60 years or above in developed countries 5,26,30.  A medical record indicating either (1) a 
fasting plasma glucose level ≥7.0 mmol/L or ≥126 mg/dL after a minimum 12h fast or (2) a 2h post-glucose 
level (2h oral glucose tolerance test) ≥11.1 mmol/L or ≥200 mg/dL on more than one occasion, combined 
with symptoms of diabetes, confirmed the diagnosis. Impaired fasting glucose (IFG) is defined as a fasting 
blood glucose level ≥100 mg/dL (5.6 mmol/L) but ≤126 mg/dL (7.0 mmol/L). Impaired glucose tolerance 
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(IGT) is defined as a 2h OGTT > 140 mg/dL (7.8 mmol/L) but <200 mg/dL (11.1 mmol/L). Subjects with IFG 
or IGT were considered pre-diabetics and were excluded. The 2h OGTTs were performed following the 
criteria of the World Health Organizations (WHO) (75 g oral load of glucose). Body mass index (BMI) was 
calculated as (weight [kg]/height [meter]2), and waist to- hip ratio (WHR) was calculated as the ratio of 
abdomen or waist circumference to hip circumference. Subjects with type I diabetes, or those having a 
family member with type I diabetes, or rare forms of T2D subtypes (maturity onset diabetes of young 
[MODYs]), or secondary diabetes (from e.g. hemochromatosis, pancreatitis) were excluded from the 
study. The selection of controls was based on fasting glycemia <100.8 mg/dL or a 2h glucose <141.0 
mg/dL. Subjects with IFG or IGT were excluded when data were analyzed for association of variants with 
T2D. All blood samples were obtained at the baseline visits. All participants signed a written informed 
consent for the investigations. The study was reviewed and approved by the University of Oklahoma 
Health Sciences Center’s Institutional Review Board, as well as the Human Subject Protection Committees 
at the participating hospitals and institutes in India. 
 
 South Asian cohorts 
For Stage 2a replication, the Sikh component of the London Life Sciences Population (LOLIPOP) study22 
comprised 2,919 individuals (810 T2D cases and 2,018 controls) and Stage 2b the non-Sikh South Asian 
components of the LOLIPOP and the Pakistan Risk of Myocardial Infarction Study (PROMIS, and the Risk 
Assessment of Cerebrovascular Events Study [RACE]) GWA studies 22 comprised 29,157 individuals (10,971 
cases and 18,186 controls) 22. Stage 3a Punjabi-specific replication was carried out on 2,894 individuals 
(1,711 cases and 1,183 controls) of Punjabi ancestry from India as part of AIDHS/SDS, and replication 
testing amongst South Asians for Stage 3b was carried out amongst 10,817 participants (5,157 T2D cases 
and 5,660 controls) which were part of the following studies: Asian Indians from the Singapore Indian Eye 
(SINDI) study 31, the Chennai Urban Rural Epidemiology Study (CURES)32,  the Diabetes Genetics in 
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Pakistan (DGP) and UK Asian Diabetes Study (UKADS) 33, the Sri Lankan Diabetes Study (SLDS) 34.  Details of 
the contributing cohorts are provided in Supplementary Methods.  
East Asian cohorts 
Replication testing for Stage 3c was carried out on a total of 33,707 East Asians comprising 14,890 
Japanese from RIKEN (n=7,480 genotyped) and Bio Bank Japan (n=7,410 GWAS 19,35), and 18,817 
individuals of East Asian ancestry as part of the Asian Genetic Epidemiology Network (AGEN) with 
genotype data available from eight GWA studies 21.  
 
DIAGRAM (Euro-Caucasians) 
 Associations of SNPs with T2D amongst Europeans were tested in silico using results from the GWA phase 
of the DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) study comprising 47,117 subjects36.  
 
Genotyping and quality control  
Genomic DNA was extracted from buffy coats using QiaAmp blood kits (Qiagen, Chatworth, USA) or by the 
salting out procedure37. Stage 1 genome-wide genotyping was performed using a Human 660W Quad 
BeadChip panel (Illumina, USA). We performed pair wise identity-by-state (IBS) clustering in PLINK across 
all individuals to assess population stratification; no population outliers were detected. Related 
individuals with pi-hat > 0.3 and samples with <95% call rate were excluded as were SNPs with call rate 
<95%, also excluded were SNPs with Hardy-Weinberg equilibrium (HWE) P<10−6 or minor allele 
frequency <1%. After quality control, 524,216 directly genotyped SNPs in 1,616 subjects (842 cases and 
774 controls) were available for association testing. Genotyping for de novo SNPs in the replication 
samples was performed by Sequenom MassArray, BioMark HD MX/HX Genetic Analysis System by 
Fluidigm, or KASPAR (K-Bioscience Ltd, UK). Samples and SNPs with <95% call rate were excluded, or 
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that deviated from HWE at P<10-3. The associations of SNPs with T2D were tested in each cohort 
separately.   
 
Statistical analyses 
Association testing 
Associations of SNPs with T2D were tested using logistic regression and an additive genetic model. 
Gender, age, BMI and five, or ten principal components to adjust for residual population stratification 
were included as covariates. As the existing HapMap2 or HapMap3 and 1000 Genomes data do not 
include Sikhs, the five or ten principal components used for this correction were estimated using our Sikh 
population sample and not from HapMap populations. After association analyses the genomic control 
inflation factor, lambda was 1.0, so no adjustments were made (Supplementary Figures 2 a, b). 
 
In addition to analysis of directly genotyped SNPs, we performed imputation using Impute 2 program38-40, 
which determines the probability distribution of missing genotypes based on a set of known haplotypes 
and an estimated fine-scale recombination map. Imputation was based on the entire multi-ethnic 
HapMap3 reference panel of ~1.5 million autosomal SNPs with MAF>0.01 in 1,011 individuals from Africa, 
Asia, Europe and the Americas (including 1,362,138 SNPs from the Indian population of 100 Gujaratis 
from Houston [GIH]). Imputation yielded a total of 1,241,769 total passing SNPs with MAF > 1% in the Sikh 
GWAS. Imputed SNPs were analyzed using SNPTEST 38,40,  adjusted for covariates age, gender, BMI and 
five principal components, which implements frequentist tests that calculate P values, parameter 
estimates and their standard errors that account for the uncertainty due to the probability distributions of 
the imputed genotypes, and included only those SNPs with an information score of >= 0.5 in discovery 
sample as well as in all GWAS studies used for replication, a measure of the relative statistical information 
about the additive genetic effect being estimated. The genomic control value for imputed SNPs was 1.02. 
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The inbreeding coefficient and measures of autozygosity were determined using the program PLINK. We 
identified runs of homozygosity using the metrics defined in Nalls et al.41, evaluating 1 Mb autosomal 
regions with at least 50 adjacent SNPs, with a sliding window of 50 SNPs including no more than 2 SNPs 
with missing genotypes and 1 possible heterozygous genotype.  
  
Stage 2 Replication: We selected all independent association signals (r2<0.25) with P<10-3 for lookup in 
GWAS of a) the Sikh component of the LOLIPOP GWAS study 22 and b) the non-Sikh South Asian 
components of the LOLIPOP and PROMIS GWAS studies 22. A fixed-effect, inverse variance meta-analysis 
(as implemented in METAL) 42 was used to combine the results for individual studies.  
 
Stage 3 Replication: Significant association results with P<10-3 based on meta-analysis of stages 1, 2a and 
2b were selected for de novo or in silico replication in Sikh, South Asian, other Asian, and European 
populations. In addition, we selected SNPs from a Sikh-only meta-analysis of stages 1a and 2a for 
genotyping in an in-house Punjabi Sikh T2D case-control population. Signals with P<10-4 after meta-
analysis of stages 1, 2a and 3a were also genotyped in the South Asian, other Asian and European 
populations to test if they were specific to the Sikh ethnic group or spanned ethnicities. All meta-analyses 
were performed using a fixed-effects inverse variance meta-analysis implemented in METAL.  
 
MuTHER Consortium  
The MuTHER resource (www.muther.ac.uk) includes LCLs, skin and adipose tissue derived simultaneously 
from a subset of well-phenotyped healthy female twins from the Twins UK adult registry. Whole-genome 
expression profiling of the samples, each with either two or three technical replicates, were performed 
using the Illumina Human HT-12 V3 BeadChips (Illumina Inc) according to the protocol supplied by the 
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manufacturer.  Log2 transformed expression signals were normalized separately per tissue as follows: 
quantile normalization was performed across technical replicates of each individual followed by quantile 
normalization across all individuals. Genotyping was done with a combination of Illumina arrays 
HumanHap300, HumanHap610Q, 1M‐Duo and 1.2MDuo 1M. Untyped HapMap2 SNPs were imputed 
using the IMPUTE software package (v2). The number of adipose samples with genotypes and expression 
values is 776. Association between all SNPs (MAF>5%, IMPUTE info >0.8) within a gene or within 1MB of 
the gene transcription start or end site and normalized expression values were performed with the 
GenABEL/ProbABEL packages using the polygenic linear model incorporating a kinship matrix in GenABEL 
followed by the ProbABEL mmscore score test with imputed genotypes.  Age and experimental batch 
were included as cofactors.   
 
Results 
Punjabi Sikh discovery GWAS 
Clinical characteristics of the Stage 1 Punjabi Sikh T2D GWAS cohort and Stage 2a and 2b (replication) 
cohorts are described in Supplementary Table 3.  Principal components analysis revealed little population 
structure (Supplementary Figure 1). After quality control, 524,216 directly genotyped SNPs in 1,616 
subjects (842 cases and 774 controls) from 1,850 total subjects were available for association testing after 
removing samples showing cryptic relatedness through identity by descent sharing. To increase genome 
coverage, genotypes were imputed for un-typed SNPs using the HapMap3 multi-ethnic reference panel 
(see Methods), yielding a total of 1,241,769 SNPs for association analyses. The reason for choosing a 
more cosmopolitan panel and not restricting to the GIH was based on our own data showing equal 
diversity of the Sikhs from GIH and CEU, and based on previously described advantages of using a 
worldwide reference panel 39.  We performed GWAS for T2D adjusted for covariates age, gender, BMI and 
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five principal components (Supplementary Figure 1); no evidence of inflation was observed 
(Supplementary Figure 2 a,b) (see Methods) .  
 
Replication and meta-analyses in Punjabi Sikh participants  
We undertook a two-stage replication in T2D case-control samples of Punjabi Sikh ancestry (Stages 2a & 
3a in Figure 1). Lead SNPs representing 513 novel independent (r2<0.25) association signals with P <10-3 in 
the discovery GWAS (including only two previously known GWAS SNPs from TCF7L2 and IGF2BP2 and 
excluding 62 SNPs with P<10-3 from other known T2D loci) were tested for in silico replication in the 
Punjabi Sikh sub-component of the London Life Sciences Population (LOLIPOP) GWAS study comprising 
801 T2D cases and 2,018 controls (Supplementary Table 1). Top SNPs representing 66 putatively novel 
signals with P<10-4 after Stage 1 & 2a meta-analysis using a fixed effects, inverse-variance approach were 
directly genotyped in the stage 3a sample of 2,894 Punjabi Sikh individuals (1,711 T2D cases and 1,183 
controls) (Figure 1, Supplementary Table 2).  
 
In a combined meta-analysis of the three Punjabi studies (n=7,329), we identified one new locus reaching 
genome-wide significance (P< 5x10-8) along with robust replication of the established SNP rs7903146 in 
TCF7L2 (P= 3.32x10-19) in Sikhs (Figures 2-4). This novel association signal lies in a 164 kb region of strong 
LD at 13q12 (harboring genes sarcoglycan, gamma SGCG and sacsin, SACS) and is represented by a directly 
genotyped intronic SNP, rs9552911 in SGCG (OR=0.67, 95%CI [0.58-0.77], P= 1.82x10-8) for the minor ‘A’ 
allele (Table 1, Figure 4, Supplementary Table 5). Excluding BMI from logistic regression model did not 
affect the association (Supplementary Table 6). Furthermore, including 5 additional principal components 
in the model did not attenuate the signal, indeed, the effect and significance was slightly improved 
(Supplementary Table 6). The genetic variance (R2) explained by this variant for T2D phenotype in Punjabi 
Sikh discovery and replication sets was 1.57%, 1.34%, respectively. There were 15 additional independent 
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loci with suggestive evidence (P<10-5 to <10-7) of association included six unknown regions along with 
IGF2BP2 originally identified in Caucasians43 (Supplementary Table 5). Meta-analysis results including 
non-Sikh Punjabis from PROMIS (Pakistan) revealed suggestive association (P<10-5 to <10-7) at SNPs from 
three new regions: chromosome 18q21 ZBTB7C (rs1893835), 20q13, near HMG1L1/CTCFL/RBM38/PCK1 
(rs328506), and at 5q33 (rs17053082) (Supplementary Table 7).  
 
Replication/evaluation and meta-analysis in other South Asians 
In order to identify T2D association signals common to Punjabi and other South Asian populations, we 
tested for association of the 513 top independent signals (P<10-3) derived from the discovery cohort in 
GWAS from the LOLIPOP, PROMIS, and RACE studies as part of Stage 2b replication (10,971 T2D cases  
and 18,186 controls) (Figure 1, Supplementary Table 1). 31 signals (P<10-4 from an interim analysis with 
Stage 2b) were further genotyped in 10,817 South Asians (5,157 T2D and 5,660 controls) (Figure 1) as part 
of Stage 3b replication. Clinical characteristics of the Stage 3 replication cohorts are described in 
Supplementary Table 4. Combined South Asian meta-analysis revealed nominally significant association in 
6 SNPs with MAF >5% (P<10-4), but only the two previously known SNPs in TCF7L2 and IGF2BP2 reached 
genome-wide significance (Table 1, Supplementary Table 8). These suggestive novel signals included SNPs 
at chromosome 20q13, near HMG1L1/CTCFL/RBM38/PCK1 (rs328506), 7q32 near PLXNA4 (rs1593304), 
3p21 in SCAP (rs4858889) and at 5p11 represented by rs13155082 (Supplementary Table 8). Further 
studies and replication in a larger sample will be required to validate these results and identify causal 
variants at these loci.  
 
Multi-ethnic replication and meta-analysis  
To  identify T2D signals spanning ethnicities, we extended replication of 31 SNPs with P<10-4  in Punjabis 
and South Asians (Stage 3b) to East Asians  (AGEN+) and Europeans (DIAGRAM+) in Stages 3c and 3d 
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respectively (Figure 1). Upon meta-analysis of 31 loci in Asians (South Asians and AGEN+), genome-wide 
associations were only seen in TCF7L2 (rs7903146, P=1.93 x10-38) and IGF2BP2 (rs1470579, P=1.54x10-13) 
(Supplementary Table 9). In joint multi-ethnic meta-analysis on 128,127 individuals from 27 studies, only 
two previously known loci TCF7L2 (rs7903146, P=8.53x10-75) and IGF2BP2 (rs1470579, P=1.81x10-19) 
showed robust associations. Interestingly, none of the Punjabi hits could be independently confirmed in 
AGEN+ or DIAGRAM+ (notably the lead rs9552911 variant from SGCG was monomorphic in DIAGRAM+) 
(Table 1, Supplementary Table 10). Lookup of 50 Kb upstream and downstream of SNPs within the SGCG 
locus in the publicly available data of MAGIC Study on glycemic trait GWAS 44,45 revealed several nominal 
associations of SNPs with fasting blood glucose and two hour glucose levels (Supplementary Figure 3). 
Some of these SNPs also showed association with fasting blood glucose and waist or WHR in Sikhs 
(Supplementary Table 11) , but none of these were  in LD (r2>0.20)  with our lead SNP.  
 
Gene Expression studies 
We examined expression of SGCG and neighboring genes (FLJ46358, MIPEP, SACS, TNFRSF19) within 1 Mb 
of the index SNP by cis-expression quantitative trait locus (eQTL) analysis using adipose tissue, skin and 
lymphoblastic cell lines (LCL) gene expression data from the MuTHER consortium comprising healthy 
female twins of European ancestry from Britain. (www.muther.ac.uk).   Several SNPs in the SGCG region 
were associated with significantly elevated (PeQTL10
-4 to 10-9) expression of SGCG mRNA in adipose tissues 
(Supplementary Table 12, Supplementary Figure 4). One adipose eQTL from MuTHER (rs572303; 
PeQTL=5.47x10
-4) located within SGCG showed a nominally significant association with increased waist 
circumference in Sikhs (β=0.67, P= 5.2x10-2) (Supplementary Table 11). As shown in Supplementary Figure 
4, the LD patterns in the region (~1.46 Mb) surrounding SGCG variant (rs9552911) varied in East Asians 
(JPT), Africans (YRI), Caucasians (CEU), Gujarati Indians (GIH) and Sikhs. Interestingly, in Caucasians and 
Yorubians, this variant was monomorphic. However, several alternative SNPs from this region in 
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Europeans were associated with fasting blood glucose (MAGIC study, r2 ranging from 0.10-0.20) and 
mRNA expression in adipose tissues in MuTHER Study (r2 ranging from 0.14-0.26) with the index SNP 
(rs9552911). These data suggest that the population differences may underlie the weak LD. It is possible 
that a single causal variant may be responsible for these associations but LD may differ between Sikhs, 
Europeans, and other populations.  
 
Comparative analysis of autozygosity  
We further to compare distributions of inbreeding coefficients and autozygosity as described by  Nalls  et 
al,41. As expected, the inbreeding coefficients in our sample were  higher compared to two outbred 
populations of European Americans- Coriell and BLSA (F=0.041 +/- 0.018 in Sikhs vs. F=0.007 +/- 0.019 in 
Coriell  and F =-0.3 +/- 0.012 in BLSA), as assessed by Nalls et al,41.  However, these results were similar to 
other Indian populations previously reported by Reich et al.46. No significant difference in inbreeding was 
observed between cases and controls (P=0.59).  Autozygosity analysis determined that there were 19 +/- 
7 homozygous segments over 1 Mb in length, with average length of 2.0 +/- 0.95 Mb. Hence, fewer but 
longer autozygous segments were found than in outbred populations. No correlation of measures of 
autozygosity to age was observed (P>0.05) across decades of age.  
 
Discussion and conclusions  
In this GWAS and a multi-stage meta-analysis, a novel locus at 13q12 in the SGCG gene (rs9552911; P= 
1.82x10-8) was identified to be associated with T2D susceptibility in Punjabi Sikhs from Northern India. 
SGCG is a member of sarcoglycan complex of transmembrane glycoproteins associated with autosomal 
recessive muscular dystrophy, in particular limb-girdle muscular dystrophy type 2C (LGMD2C). SGCG is 
expressed in skeletal muscles and its high expression is also seen in vascular smooth muscle cells as well 
as in breast cancer cell lines 47,48. Founder mutations in SGCG causing LGMD2C predate migration of 
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Romani gypsies of Europe out of India around 1100 AD 49. Due to complete endogamy, this genetically 
isolated community had an increased incidence of autosomal recessive LGMD2C. SGCG targeted knockout 
mice displayed a variety of phenotypes including dystrophic cardiomyopathy, defects in skeletal muscle, 
metabolism, homeostasis, growth, apoptosis, aging, and behavior 50-53. Mice lacking sarcoglycan complex 
including the SGCG in adipose and skeletal muscle were shown to be glucose intolerant and exhibited 
whole body insulin resistance due to impaired insulin-stimulated glucose uptake in skeletal muscles 54. 
 
The allelic distribution of the less common ‘A’ (protective) allele of rs9552911 ranged from 0.06 to 0.15 in 
South Asians and differed among other South Asians (0.11) and Punjabi Sikhs (0.08) for this SNP (see 
details in Supplementary Table 13). Perhaps allele frequency difference may account for the lack of 
replication in non-Sikh South Asians. Further replication in large independent datasets of South Asians and 
Punjabi Sikhs would be needed to explain this observed association. In view of the complex racial history 
complicated by a well-defined caste system, Indian populations display a great deal of genetic and cultural 
diversity 55. Studies suggest that genetic affinity among endogamous communities in India is inversely 
correlated with geographic distance between them 23. Therefore, it is possible that undetected causal 
variant(s) or multiple rare variants in LD with this marker arose on a haplotype tagged by rs9552911 in 
Punjabi Sikhs after divergence from other South and West Indian populations. This variation in the index 
SNP rs9552911 does not appear to be of recent origin as suggested by comparative genomic analysis 
(Supplementary Figure 5). Two important nuclear hormone receptors and transcription factors (PPAR 
gamma (1 and 2) and PPAR alpha) bind on the promoter and intron 1 of the SGCG. Further, the maturity 
onset diabetes of young-4 [MODY4] locus at chromosome 13q12 represented by insulin promoter factor 1 
or PDX-1 lies next to the SGCG locus. Therefore, further in-depth examination by targeted resequencing in 
the extended region and functional studies may reveal putative causative variants in this extended region 
and provide insight into the physiological relevance of the observed association.   
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In summary, our study identified a novel locus associated with T2D in a population of Punjabi Sikh 
ancestry from Northern India. These findings provide new information not only on previously unknown 
regions associated with T2D but demonstrate a putative population-specific association which could lead 
to additional biological insights into T2D pathogenesis.  
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Figure Legends  
 
Figure 1. Summary of study design and outcome of key findings 
 
Figure 2a and 2b. Manhattan plot in Figure 2a show  primary genome-wide association analysis of the 
Punjabi Sikh discovery cohort using directly genotyped (533,977) SNPs and  Manhattan plots in Figure 2b 
show imputed 1,241,769 SNPs on X axis and -log10 p value of association on Y axis.  Locations of the three 
loci (including one novel locus at the SGCG) reached genome-wide significance after combined analysis of 
the GWAS and replication data in Punjabi Sikhs. 
 
Figures 3a and 3b. Figure 3a shows regional association plot for a new T2D locus detected at 13q12 in the 
SGCG gene in from the genome-wide meta-analysis in Sikhs. Figure 3b shows a strong confirmation of  
SNPs in the TCF7L2  in Sikh meta-analysis.  In these plots, for SNP showing the most strongly associated 
signal are depicted as a red diamond for the combined stage 1, 2a and 3a results for meta-analysis and 
purple diamond shows evidence of association for the stage 1 results. Each circle in color shows a SNP 
with a color- scale relating the r2 value for that SNP and the top SNP taken from HapMap 3 GIH panel.  We 
present LD using the GIH panel, the closest HapMap population to the Sikhs; however, we note that there 
could still be differential LD between the reference panel and the Sikh population. At the bottom of the 
plot, the locations of known genes in the region are shown.   
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Figure 4: Forest plot showing association of lead SNP in the SGCG (rs9552911) with type 2 diabetes. For 
each study, the estimates of odds ratios with 95% CI are shown. In addition, meta-analysis of Sikhs, South 
Asians, and multi-ethnic studies are shown at the bottom.  Meta-analysis in Sikhs show a significant 
association of rs9552911 with T2D (OR 0.67[0.58-0.77], P=1.82x10-8]  
23 
 
 
Table 1. GWAS, replication, and meta-analysis results of  T2D  loci identified in Punjabi Sikhs   
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